Response: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
Sung Woo Kim (Kim SW), Keun-Gyu Park (Park KG)
Diabetes Metab J. 2018;42(4):350-352.   Published online 2018 Aug 21     DOI: https://doi.org/10.4093/dmj.2018.0138
Citations to this article as recorded by Crossref logo
PCSK9: Associated with cardiac diseases and their risk factors?
Yanan Guo, Binjie Yan, Shi Tai, Shenghua Zhou, Xi-Long Zheng
Archives of Biochemistry and Biophysics.2021; 704: 108717.     CrossRef
Gut Lactobacillus Level Is a Predictive Marker for Coronary Atherosclerotic Lesions Progress and Prognosis in Patients With Acute Coronary Syndrome
Jing Gao, Jie Wang, Li-Li Zhao, Ting-Ting Yao, Yang Chen, Jing Ma, Xu Zhang, Jing-Xian Wang, Yuan Wang, Zhuang Cui, Yin Liu
Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
Butein Synergizes with Statin to Upregulate Low-Density Lipoprotein Receptor ThroughHNF1α-Mediated PCSK9 Inhibition in HepG2 Cells
Jin-Taek Hwang, Hyo Jin Kim, Hyo-Kyoung Choi, Jae-Ho Park, Sangwon Chung, Min-Yu Chung
Journal of Medicinal Food.2020; 23(10): 1102.     CrossRef